Defunct Company
Total Trials
14
As Lead Sponsor
11
As Collaborator
3
Total Enrollment
1,060
NCT02697188
Pilot Pharmacokinetic Study of Oral Testosterone Ester Formulations in Hypogonadal Men
Phase: Phase 2
Role: Lead Sponsor
Start: Nov 30, 2007
Completion: Apr 30, 2008
NCT00695110
Pharmacokinetic Study of Oral Testosterone (T) Ester Formulations in Hypogonadal Men
Start: Jun 30, 2008
Completion: Aug 31, 2009
NCT00911586
Pharmacokinetic Study to Determine Time to Steady-state
Start: Jul 31, 2009
Completion: Jan 31, 2010
NCT00924612
Study to Determine the Effect of Food on the Absorption of an Oral Testosterone Undecanoate Formulation
Completion: Jul 31, 2010
NCT01403116
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase: Phase 3
Start: Jul 31, 2011
Completion: Sep 30, 2013
NCT01699178
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Start: Aug 31, 2012
Completion: Apr 30, 2014
NCT01765179
Safety and Efficacy Trial of Testosterone Undecanoate
Start: Jan 31, 2013
Completion: Jul 31, 2013
NCT02670343
Phlebotomy Study of Testosterone Undecanoate
Phase: Phase 1/2
Start: Jan 31, 2016
Completion: Mar 31, 2016
NCT02722278
A Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Start: Mar 31, 2016
Completion: Nov 30, 2016
NCT02921386
The Effect of Various Amounts of Fat on PK of Oral Testosterone Undecanoate
Start: Oct 31, 2016
Completion: Jan 21, 2017
NCT03973840
Assessment of Blood From Men Receiving Oral TU in Various Collection Tubes
Phase: Phase 1
Start: Jul 15, 2018
Completion: Jul 31, 2018
NCT04983940
Patient Satisfaction After Switching to Oral Testosterone Undecanoate
Phase: Phase 4
Role: Collaborator
Start: Jun 18, 2021
Completion: Apr 6, 2023
NCT05081193
Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer
Start: Mar 7, 2022
Completion: Aug 4, 2025
NCT05249634
Testosterone Treatment in Men with Chronic Kidney Disease
Start: Mar 15, 2022
Completion: Dec 31, 2028